Literature DB >> 20605703

Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.

Hencelyn Chu1, Anatoly Slepenkin, Mikael Elofsson, Pia Keyser, Luis M de la Maza, Ellena M Peterson.   

Abstract

Vaginal microbicides with activity towards organisms that cause sexually transmitted infections have been proposed as a strategy to reduce transmission. Small-molecule inhibitors of Chlamydia trachomatis serovar D belonging to the class of salicylidene acylhydrazides (INPs) have been shown to work through a mechanism that involves iron restriction. Expanding on this work, ten INPs were tested against a lymphogranuloma venereum strain of C. trachomatis (serovar L2), Neisseria gonorrhoeae, and hydrogen peroxide-producing Lactobacillus crispatus and Lactobacillus jensenii. Seven INPs had minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations of <50 microM towards C. trachomatis L2. Three INPs had a MIC <12.5 microM against N. gonorrhoeae. Inhibition was reversed by iron, holo-transferrin and holo-lactoferrin but not by the iron-poor forms of these compounds. The compounds exhibited no bactericidal activity toward Lactobacillus. The INPs were not cytotoxic to HeLa 229 cells. When INP 0341 was tested in a mouse model of a Chlamydia vaginal infection there was a significant reduction in the number of mice shedding C. trachomatis up to 4 days after infection (P<0.01). In summary, select INPs are promising vaginal microbicide candidates as they inhibit the growth of two common sexually transmitted organisms in vitro, are active in a mouse model against C. trachomatis, are not cytotoxic and do not inhibit organisms that compose the normal vaginal flora. Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605703      PMCID: PMC2902681          DOI: 10.1016/j.ijantimicag.2010.03.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  37 in total

1.  Cytotoxicity and DNA-damage in human lung epithelial cells exposed to respirable alpha-quartz.

Authors:  Carla Fanizza; Cinzia Lucia Ursini; Emilia Paba; Aureliano Ciervo; Arianna Di Francesco; Raffaele Maiello; Paolo De Simone; Delia Cavallo
Journal:  Toxicol In Vitro       Date:  2006-12-16       Impact factor: 3.500

Review 2.  The real-time polymerase chain reaction.

Authors:  Mikael Kubista; José Manuel Andrade; Martin Bengtsson; Amin Forootan; Jiri Jonák; Kristina Lind; Radek Sindelka; Robert Sjöback; Björn Sjögreen; Linda Strömbom; Anders Ståhlberg; Neven Zoric
Journal:  Mol Aspects Med       Date:  2006-02-03

Review 3.  Microbicides for prevention of transmission of sexually transmitted diseases.

Authors:  Mary K Howett; Jeffrey P Kuhl
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

4.  Genital chlamydial infection in STD patients: its relation to HIV infection.

Authors:  A G Joyee; S P Thyagarajan; E V Reddy; C Venkatesan; M Ganapathy
Journal:  Indian J Med Microbiol       Date:  2005-01       Impact factor: 0.985

5.  Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.

Authors:  Anatoly Slepenkin; Per-Anders Enquist; Ulrik Hägglund; Luis M de la Maza; Mikael Elofsson; Ellena M Peterson
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

6.  Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides.

Authors:  Anna M Kauppi; C David Andersson; Henrik A Norberg; Charlotta Sundin; Anna Linusson; Mikael Elofsson
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

7.  The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania.

Authors:  Saidi H Kapiga; Noel E Sam; Heejung Bang; Quanhong Ni; Trong T H Ao; Ireen Kiwelu; Sarah Chiduo; Uzodinma Ndibe; George Seage; Paul Coplan; John Shao; Zeda F Rosenberg; Max Essex
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

8.  Examination of an inducible expression system for limiting iron availability during Chlamydia trachomatis infection.

Authors:  Brian D Dill; Jane E Raulston
Journal:  Microbes Infect       Date:  2007-04-07       Impact factor: 2.700

9.  Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months.

Authors:  Andrew Vallely; Stella Kasindi; Ian R Hambleton; Louise Knight; Tobias Chirwa; Rebecca Balira; John Changalucha; Deborah Watson-Jones; Dean Everett; Awene Gavyole; Jocelyn Moyes; Mar Pujades-Rodríguez; David A Ross; Richard J Hayes
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

10.  Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.

Authors:  Richard A Cone; Timothy Hoen; Xixi Wong; Raed Abusuwwa; Deborah J Anderson; Thomas R Moench
Journal:  BMC Infect Dis       Date:  2006-06-01       Impact factor: 3.090

View more
  14 in total

1.  Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.

Authors:  Anatoly Slepenkin; Hencelyn Chu; Mikael Elofsson; Pia Keyser; Ellena M Peterson
Journal:  J Infect Dis       Date:  2011-09-20       Impact factor: 5.226

2.  N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.

Authors:  Sania Marwaha; Hanna Uvell; Olli Salin; Anders E G Lindgren; Jim Silver; Mikael Elofsson; Asa Gylfe
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  In vitro anti-HIV-1 activity of salicylidene acylhydrazide compounds.

Authors:  Donald N Forthal; Tran B Phan; Anatoly V Slepenkin; Gary Landucci; Hencelyn Chu; Mikael Elofsson; Ellena Peterson
Journal:  Int J Antimicrob Agents       Date:  2012-07-20       Impact factor: 5.283

4.  The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.

Authors:  Pia Uusitalo; Ulrik Hägglund; Elin Rhöös; Henrik Scherman Norberg; Mikael Elofsson; Charlotta Sundin
Journal:  J Antibiot (Tokyo)       Date:  2017-06-07       Impact factor: 2.649

5.  Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.

Authors:  Jianfang Li; Chao Lv; Weiyang Sun; Zhenyu Li; Xiaowei Han; Yaoyao Li; Yuemao Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

6.  In Vitro Activity of Quaternary Ammonium Surfactants against Streptococcal, Chlamydial, and Gonococcal Infective Agents.

Authors:  Ângela S Inácio; Alexandra Nunes; Catarina Milho; Luís Jaime Mota; Maria J Borrego; João P Gomes; Winchil L C Vaz; Otília V Vieira
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

7.  A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo.

Authors:  Ludmila N Nesterenko; Nailya A Zigangirova; Egor S Zayakin; Sergey I Luyksaar; Natalie V Kobets; Denis V Balunets; Ludmila A Shabalina; Tatiana N Bolshakova; Olga Y Dobrynina; Alexander L Gintsburg
Journal:  J Antibiot (Tokyo)       Date:  2016-01-06       Impact factor: 2.649

8.  Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections.

Authors:  Michelle M Butler; Samanthi L Waidyarachchi; Kristie L Connolly; Ann E Jerse; Weirui Chai; Richard E Lee; Stephan A Kohlhoff; Dean L Shinabarger; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

9.  Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion.

Authors:  Tofeeq Ur-Rehman; Anatoly Slepenkin; Hencelyn Chu; Anders Blomgren; Markus K Dahlgren; Caroline E Zetterström; Ellena M Peterson; Mikael Elofsson; Asa Gylfe
Journal:  J Antibiot (Tokyo)       Date:  2012-06-06       Impact factor: 2.649

10.  Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds.

Authors:  Dai Wang; Caroline E Zetterström; Mads Gabrielsen; Katherine S H Beckham; Jai J Tree; Sarah E Macdonald; Olwyn Byron; Tim J Mitchell; David L Gally; Pawel Herzyk; Arvind Mahajan; Hanna Uvell; Richard Burchmore; Brian O Smith; Mikael Elofsson; Andrew J Roe
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.